Sanofi (SNY)
NASDAQ: SNY · Real-Time Price · USD
48.74
+0.69 (1.44%)
At close: Aug 13, 2025, 4:00 PM
49.00
+0.26 (0.53%)
After-hours: Aug 13, 2025, 7:59 PM EDT
Sanofi Revenue
Sanofi had revenue of 10.74B EUR in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to 45.74B, up 15.65% year-over-year. In the year 2024, Sanofi had annual revenue of 44.29B with 7.73% growth.
Revenue (ttm)
45.74B EUR
Revenue Growth
+15.65%
P/S Ratio
2.21
Revenue / Employee
551,871 EUR
Employees
82,878
Market Cap
118.83B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 44.29B | 3.18B | 7.73% |
| Dec 31, 2023 | 41.11B | 805.00M | 2.00% |
| Dec 31, 2022 | 40.30B | 1.13B | 2.88% |
| Dec 31, 2021 | 39.18B | 1.81B | 4.83% |
| Dec 31, 2020 | 37.37B | -262.00M | -0.70% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
SNY News
- 1 day ago - Sanofi stops supply of high cholesterol drug to China due to limited availability - Reuters
- 6 days ago - Sanofi: Playing To Win - Seeking Alpha
- 8 days ago - Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc. - GlobeNewsWire
- 12 days ago - Pharmaceutical makers were largely unshaken by new demands from President Trump to lower drug prices, with experts saying the measures would either have modes impact or face legal challenges - WSJ
- 12 days ago - European drugmakers fall after Trump raises stakes over US drug price cuts - Reuters
- 13 days ago - Sanofi (SNY) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Pharma Companies Should Immediately Cut Down Drug Prices, Trump Says - Forbes
- 13 days ago - Trump pressures 17 pharma CEOs to cut US drug prices - Reuters